After studying the issue, the US Preventive Services Task Fore (USPSTF) cannot recommend for or against the routine screening for dyslipidemia in children, adolescents, and young adults (up to 20 years of age).[more]
FDA approves Crenessity for treatment of classic congenital adrenal hyperplasia
The FDA has approved Crenessity for managing classic CAH in patients 4 years and up, reducing steroid doses while controlling hormones, offering a safer treatment option.
Food Insecurity and the Dangers of Infant Formula Dilution
Keeping up with type 1 diabetes technology changes in primary care
A discussion of the evolving landscape of diabetes technology and its implications for primary care providers.
Demystifying Infant Formula
Antiseizure medications used in pregnancy linked to neurodevelopmental risks in children
Prenatal exposure to antiseizure medications like valproate and topiramate raises risks of ASD, ADHD, and ID in children; lamotrigine shows no increased risk.
COVID-19 Therapy Roundtable: focusing on inpatient care
In this episode, the panel discusses therapies and care around inpatients including mechanical ventilation, extracorporeal membrane oxygenation (ECMO), and remdesivir.